/Teleflex%20Incorporated%20logo%20on%20phone-by%20rafapress%20via%20Shutterstock.jpg)
Teleflex has continued to underperform the broader market over the past several years, yet analysts remain moderately bullish on the stock’s prospects.
/Steris%20Plc%20logo%20and%20chart-by%20Piotr%20Swat%20via%20Shutterstock.jpg)
STERIS has underperformed the broader market over the past year, but analysts are highly optimistic about the stock’s prospects.
/Insulet%20Corporation%20insulin%20monitor-by%20Maria%20Wan%20via%20Shutterstock.jpg)
Insulet has outperformed the broader market over the past year, and analysts are highly optimistic about the stock’s prospects.
/Resmed%20Inc_%20HQ%20photo-by%20JHVEPhoto%20via%20iStock.jpg)
ResMed has outperformed the broader market over the past year, and analysts are moderately optimistic about the stock’s prospects.
/Becton%20Dickinson%20%26%20Co_%20office%20building-by%20JHVEPhoto%20via%20Shutterstock.jpg)
MedTech giant Becton, Dickinson and Company underperformed relative to the broader market over the past year, but Wall Street analysts remain upbeat about the stock’s potential.
/Zimmer%20Biomet%20Holdings%20Inc%20HQ%20photo-by%20jetcityimage%20via%20iStock.jpg)
Despite trailing the broader market over the past year, Zimmer Biomet still holds a moderately favorable outlook among analysts.
/Hologic%2C%20Inc_%20%20magnified%20-by%20Casimiro%20PT%20via%20Shutterstock.jpg)
Hologic has observed a significant drop in stock prices recently and analysts are taking a more cautious stance on the company’s prospects.
/Edwards%20Lifesciences%20Corp%20Irvine%2C%20Ca%20campus-by%20Steve%20Cukrov%20via%20Shutterstock.jpg)
Edwards Lifesciences has underperformed the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.
/Abbott%20Laboratories%20HQ%20photo-%20by%20Sundry%20Photography%20via%20iStock.jpg)
Abbott Laboratories has underperformed the broader market over the past year, but analysts are highly optimistic about the stock’s prospects.
/Medtronic%20Plc%20HQ-by%20JHVEPhoto%20via%20iStock.jpg)
Medtronic has underperformed the broader market over the past year, and analysts are moderately optimistic about the stock’s prospects.